{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:46:02Z","timestamp":1769129162785,"version":"3.49.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Tuberculosis"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ijtb.2025.03.001","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T23:07:59Z","timestamp":1741302479000},"page":"537-539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic Drug Monitoring-how to tackle non-responsive drug sensitive tuberculosis"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2253-1518","authenticated-orcid":false,"given":"Ashish Kumar","family":"Prakash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinkita","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishant","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinky","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijtb.2025.03.001_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4103\/ijmr.IJMR_1961_16","article-title":"Intrapatient variability in plasma rifampicin & isoniazid in tuberculosis patients","volume":"147","author":"Kumar","year":"2018","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.ijtb.2025.03.001_bib2","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s40265-014-0222-8","article-title":"Therapeutic drug monitoring in the treatment of tuberculosis: an update","volume":"74","author":"Alsultan","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.ijtb.2025.03.001_bib3","unstructured":"World Health Organization. Index-TB Guidelines: Guidelines on Extra-pulmonary Tuberculosis in India."},{"key":"10.1016\/j.ijtb.2025.03.001_bib4","unstructured":"National TB Elimination Programme, Central TB Division. Training Modules for Programme Managers & Medical Officers. Ministry of Health & Family Welfare, Government of India. https:\/\/tbcindia.gov.in\/index1.php?lang=1&level=1&subkind=5465&lid=3540 Last accessed on 11 March 2022."},{"issue":"12","key":"10.1016\/j.ijtb.2025.03.001_bib5","article-title":"The role of therapeutic drug monitoring in slow response extra-pulmonary tuberculosis treatment: a case report","volume":"15","author":"Aldrees","year":"2023","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.ijtb.2025.03.001_bib6","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1378\/chest.120.5.1520","article-title":"Utility of rifampin blood levels in the treatment and follow-up of active pulmonary tuberculosis in patients who were slow to respond to routine directly observed therapy","volume":"120","author":"Mehta","year":"2001","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ijtb.2025.03.001_bib7","first-page":"225","article-title":"Therapeutic drug monitoring in the treatment of active tuberculosis","volume":"18","author":"Babalik","year":"2011","journal-title":"Can Respir J J Can Thorac Soc"},{"key":"10.1016\/j.ijtb.2025.03.001_bib8","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1093\/infdis\/jir658","article-title":"Multidrug-resistant tuberculosis not due to noncompliance but to between patient pharmacokinetic variability","volume":"204","author":"Srivastava","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijtb.2025.03.001_bib9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1592\/phco.29.5.503","article-title":"Therapeutic drug monitoring of antimycobacterial drugs in patients with both tuberculosis and advanced human immunodeficiency virus infection","volume":"29","author":"Holland","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijtb.2025.03.001_bib10","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1378\/chest.113.5.1178","article-title":"Low serum antimycobacterial drug levels in non-HIV-infected tuberculosis patients","volume":"113","author":"Kimerling","year":"1998","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ijtb.2025.03.001_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0272-5231(05)70357-9","article-title":"Using therapeutic drug monitoring to dose the antimycobacterial drugs","volume":"18","author":"Peloquin","year":"1997","journal-title":"Clin Chest Med"},{"issue":"12","key":"10.1016\/j.ijtb.2025.03.001_bib12","first-page":"1290","article-title":"Paradoxical response during anti-tuberculosis treatment in HIV-negative patients with pulmonary tuberculosis","volume":"11","author":"Cheng","year":"2007","journal-title":"Int J Tubercul Lung Dis"}],"container-title":["Indian Journal of Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570725000782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570725000782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T04:07:58Z","timestamp":1758254878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019570725000782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0019570725000782"],"URL":"https:\/\/doi.org\/10.1016\/j.ijtb.2025.03.001","relation":{},"ISSN":["0019-5707"],"issn-type":[{"value":"0019-5707","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Drug Monitoring-how to tackle non-responsive drug sensitive tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijtb.2025.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Tuberculosis Association of India. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}